Skip to main content
logo
Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
1.070
-0.050 (-4.46%)
At close: Sep 18, 2026, 4:00 PM EDT
1.100
+0.030 (2.80%)
After-hours: Sep 18, 2026, 7:30 PM EDT

Cadrenal Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
4162610-
Market Cap Growth
-85.25%-38.62%168.05%--
Enterprise Value
112211-
Last Close Price
1.076.7814.4911.10-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
0.815.793.471.25-
P/TBV Ratio
0.935.793.471.25-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
---0.00-0.11
Net Debt / Equity Ratio
-0.58-1.46-1.35-1.09-0.11
Net Debt / EBITDA Ratio
0.210.300.911.10-0.21
Net Debt / FCF Ratio
0.240.321.362.37-0.46
Quick Ratio
3.392.533.7510.210.02
Current Ratio
3.732.723.7710.270.55
Return on Equity (ROE)
-275.16%-260.11%-140.78%-780.59%-
Return on Assets (ROA)
-125.93%-116.44%-73.49%-102.62%-
Return on Capital Employed (ROCE)
-284.80%-491.50%-147.30%-99.20%529.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-302.41%-83.50%-41.24%-86.73%-
FCF Yield
-266.27%-79.53%-28.51%-36.67%-
Buyback Yield / Dilution
-44.92%-63.48%-35.59%-70.99%-
SEC Filings: 10-K · 10-Q